Search results
Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. REGN delivered better-than-expected fourth-quarter 2022 results even...
Regeneron (REGN) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for Regeneron (REGN). Shares have lost about 2.3%...
Will Loss of REGEN-COV Sales Hurt Regeneron (REGN) in 2022?
Zacks via Yahoo Finance· 2 years agoBiotech giant Regeneron Pharmaceuticals REGN witnessed a massive surge in sales in 2021, driven by...
Regeneron (REGN) Outperforms YTD: What's in Store for 2023?
Zacks via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals, Inc. REGN is having a good run, with shares gaining 16.4% in the year so...
If You Invested $1000 in Regeneron 10 Years Ago, This Is How Much You'd Have Now
Zacks via Yahoo Finance· 2 years agoFor most investors, how much a stock's price changes over time is important. This factor can impact...
If You Invested $10,000 in Regeneron Pharmaceuticals 5 Years Ago, This Is How Much You Would Have...
Motley Fool· 2 years agoRegeneron Pharmaceuticals (NASDAQ: REGN) has been a reliable, steadily growing stock over the years,...
Amgen-Sanofi patent case divides makers of antibody drugs
Reuters via Yahoo News· 1 year agoAmgen Inc's battle with Sanofi and Regeneron at the U.S. Supreme Court over its cholesterol drug...
U.S. health agency, Regeneron extend partnership to develop monoclonal antibodies
Reuters via Yahoo Finance· 9 months agoSept 8 (Reuters) - The U.S. Department of Health and Human Services said on Friday that it is extending its contract with Regeneron Pharmaceuticals to develop monoclonal antibodies as part of ...
US govt awards $1.4 billion for development of new COVID therapies, vaccines
Reuters via Yahoo News· 10 months agoThe funding to Regeneron is a part of a $5 billion initiative dubbed "Project NextGen" by the U.S....
EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial
Benzinga via Yahoo Finance· 1 year agoSAB Biotherapeutics Inc (NASDAQ: SABS) has revealed topline results from the Phase 3 National...